BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25936538)

  • 1. Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8.
    Tang B; Zhou W; Du J; He Y; Li Y
    Mol Med Rep; 2015 Aug; 12(2):1741-52. PubMed ID: 25936538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen.
    Li Y; Zhou W; Du J; Jiang C; Xie X; Xue T; He Y
    Cancer Immunol Immunother; 2015 Feb; 64(2):259-69. PubMed ID: 25376540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.
    Lu H; Tang B; He Y; Zhou W; Qiu J; Li Y
    Mol Med Rep; 2016 Dec; 14(6):4999-5006. PubMed ID: 27840923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prediction and Identification of HLA-A*0201 Restricted CTL Epitopes from Eps8].
    Du JW; Wang YX; Zhou WJ; Jiang CJ; Xie XL; Zhang HH; He YJ; Li YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):865-72. PubMed ID: 27342524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
    Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
    J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design.
    Zhang J; Yang J; Fan D; Tao H; Wang H; Yu T
    Oncol Rep; 2013 May; 29(5):1955-61. PubMed ID: 23503586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.
    Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y
    Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel T cell epitopes from efflux pumps of Mycobacterium tuberculosis.
    Zhu YH; Gao YF; Chen F; Liu W; Zhai MX; Zhai WJ; Qi YM; Ye Y
    Immunol Lett; 2011 Oct; 140(1-2):68-73. PubMed ID: 21756938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
    Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ
    J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human hepsin as novel targets for prostate cancer immunotherapy.
    Guo J; Li G; Tang J; Cao XB; Zhou QY; Fan ZJ; Zhu B; Pan XH
    Scand J Immunol; 2013 Sep; 78(3):248-57. PubMed ID: 23721092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity.
    Xie X; Zhou W; Hu Y; Chen Y; Zhang H; Li Y
    Cell Death Dis; 2018 Mar; 9(3):379. PubMed ID: 29515106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia.
    Bai J; Wang J; Yang Y; Wang F; He A; Zhang W
    J Immunother; 2021 May; 44(4):141-150. PubMed ID: 33596023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
    Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H
    Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel HLA-A(*)0201-restricted CTL epitopes from Pokemon.
    Yuan B; Zhao L; Xian R; Zhao G
    Cell Immunol; 2012; 274(1-2):54-60. PubMed ID: 22405859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.
    Chen T; Tang XD; Wan Y; Chen L; Yu ST; Xiong Z; Fang DC; Liang GP; Yang SM
    Neoplasia; 2008 Sep; 10(9):977-86. PubMed ID: 18714399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
    Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R
    Immunology; 2010 Mar; 129(3):386-95. PubMed ID: 19922423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis.
    Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J
    Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes.
    Li J; Bai J; Gu L; He A; Wang J; Wang J; Zhang P; Zhang W
    Med Oncol; 2014 Dec; 31(12):293. PubMed ID: 25355639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.